Stock Detail
TECHNE CORPORATION
Drugs
TECH @ Yahoo Finance | TECH Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $66.47 | $67.87 | $-0.75 | -1.12% | 1.10 | $67.22 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $66.66 | $66.34 | 68,783 | 2.46B | 97,644 | 21.79 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 68.42 | 67.44 | 66.89 | 65.91 | 65.36 |
Stock Profile
TECHNE Corporation, through its subsidiaries, engages in the development and manufacture of biotechnology products and hematology calibrators and controls. The company operates in two divisions, Biotechnology and Hematology. The Biotechnology division engages in the development and manufacture of cytokines and enzymes, antibodies, assay kits, clinical diagnostic kits, flow cytometry products, and intracellular cell signaling products. These products are sold to biomedical researchers and clinical research laboratories. The Hematology division develops and manufactures whole blood hematology controls and calibrators, linearity and reportable range controls, whole blood reticulocyte controls, whole blood flow cytometry controls, whole blood glucose/hemoglobin control, erythrocyte sedimentation rate control, and multipurpose platelet reference controls. These products are sold to hospitals and clinical laboratories to check the performance of hematology instruments. In addition, the company distributes biotechnology products in Europe. The company was founded in 1976 and is based in Minneapolis, Minnesota.